| Beyond vaccines: clinical status of prospective COVID-19 therapeutics S Kumar, DM Çalışkan, J Janowski, A Faist, BCG Conrad, J Lange, ... Frontiers in Immunology 12, 752227, 2021 | 28 | 2021 |
| Virus infection and systemic inflammation: lessons learnt from COVID-19 and beyond A Faist, J Janowski, S Kumar, S Hinse, DM Çalışkan, J Lange, S Ludwig, ... Cells 11 (14), 2198, 2022 | 15 | 2022 |
| & Brunotte, L.(2021). Beyond vaccines: clinical status of prospective COVID-19 therapeutics S Kumar, DM Çalışkan, J Janowski, A Faist, BCG Conrad, J Lange Frontiers in Immunology 12, 752227, 0 | 6 | |
| Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract DM Çalışkan, S Kumar, S Hinse, K Schughart, R Wiewrodt, S Fischer, ... Emerging Microbes & Infections 13 (1), 2402868, 2024 | | 2024 |
| Kırım-Kongo Kanamalı Ateşi Hastalığına (KKKAH) Karşı Geliştirilen İnaktif Aşıya Bağlı Oluşacak Hücresel İmmun Yanıtın Araştırılması İ SÖZDUTMAZ, H YETİŞKİN, DM ÇALIŞKAN, E BERBER, A KALKAN, ... | | 2016 |
